Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/132595
Title: Microinjection of human oocytes: A technique for severe oligoasthenoteratozoospermia
Authors: Ng, S.C. 
Bongso, A. 
Ratnam, S.S. 
Issue Date: 1991
Citation: Ng, S.C., Bongso, A., Ratnam, S.S. (1991). Microinjection of human oocytes: A technique for severe oligoasthenoteratozoospermia. Fertility and Sterility 56 (6) : 1117-1123. ScholarBank@NUS Repository.
Abstract: Objective: To determine outcome after microinjection with very poor quality sperm and after failed fertilization. Design: Group 1, fresh oocytes from patients with very low sperm density and motility on the day of oocyte recovery; Group 2, 1-day-old oocytes that failed to fertilize. Setting: All material was obtained from the National University Hospital. Patients: One hundred and thirty-one from group 1; 35 from group 2. Interventions: Sperm was injected subzonally or directly into the ooplasm. Main Outcome Measure: Normal and abnormal fertilization and pregnancy. Results: Subzonal transfer was done on 771 oocytes in group 1 and 188 oocytes in group 2. Multiple sperm were transferred [mean of 6.6 for group 1 and 7.3 for group 2]. Monospermic fertilization occurred in 16.6% and 14.9%, respectively. Polyspermy and parthenogenetic activation were low at 2.3% and 2.8%, respectively. Five pregnancies were obtained, but only one delivered. Ooplasmic injection (single sperm heads) was done in 38 oocytes from three patients with extremely severe oligozoospermia; only four two-pronuclear zygotes were obtained and replaced into two patients, without any resulting pregnancy. Conclusions: Subzonal transfer may be a viable technique for patients with severe sperm problems.
Source Title: Fertility and Sterility
URI: http://scholarbank.nus.edu.sg/handle/10635/132595
ISSN: 00150282
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.